<DOC>
	<DOC>NCT02880111</DOC>
	<brief_summary>Rates of DMBT1 (Glycoprotein like) in Sputum of CF Patients with or without may be different according to their Pseudomonas Aeruginosa chronic colonization status. The aim of this study is to compare rates of DMBT1 (Glycoprotein like) in Sputum of CF patients with or without a Pseudomonas Aeruginosa chronic colonization.</brief_summary>
	<brief_title>Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients With Pseudomonas Aeruginosa</brief_title>
	<detailed_description>Rates of DMBT1 (Deleted in Malignant Brain Tumor 1) will be compared between 2 groups of 30 CF patients : group 1 : with Pseudomonas Aeruginosa chronic colonization and group 2 30 CF patients without Pseudomonas Aeruginosa chronic colonization.</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>CF patient 6 to 35 years Availability of sputum Signed Informed consent Cardiac insufficiency Antiinflammatory drugs on going Oral corticosteroid therapy Inhaled corticosteroids during the two weeks before inclusion, Patient awaiting lung transplantation Patient with a past history of heart/lung transplantation Patient with a sputum examination positive for : atypical mycobacteria, Burkholderia cepacia, Stenotrophomonas maltophilia, Patient chronically colonized with multiresistant Pseudomonas aeruginosa Inhaled Colymicine® or Tobramycin® during the two weeks before inclusion Change of the CF treatment during the last 4 weeks +/ 2 days before inclusion : corticosteroid, pancreatic extracts, antisecretory drugs...</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Malignant Brain Tumor</keyword>
	<keyword>patient sputum</keyword>
</DOC>